NCT00308425View on ClinicalTrials.gov

Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS

PHASE3CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
De Novo Renal Transplantation
Interventions
DRUG

Enteric-coated Mycophenolate sodium (EC-MPS), valsartan

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY